Welcome to “MS News Notes,” a Monday morning column where I comment on multiple sclerosis (MS) news stories that caught my eye last week. Here’s a look at what’s been happening: Testing a new MRI contrast agent One concern that some people with MS have when getting an MRI…
The MS Wire — Ed Tobias
People say to write what you know and Ed Tobias knows about MS. He’s lived with the illness since 1980, when he was 32 years old. Ed’s a retired, award-winning broadcast journalist and his column combines his four decades of MS experiences with news and comments about the latest in the MS community. In addition to writing his column, Ed is one of the patient moderators on the MS News Today Facebook, Twitter, and Instagram sites. He’s also the author of “The Multiple Sclerosis Toolbox: Hints and Tips for Living with M.S.” Ed and his wife split their time between the Washington, D.C. suburbs and Florida’s Gulf Coast, trying to follow the sun.
Featured Post
This is my 823rd column for Multiple Sclerosis News Today. It is also my last. Over the past seven and a half years, I’ve written about multiple sclerosis (MS) fatigue and frustration, about treatments and travel, about neurologists (good and bad), stress,…
I nearly jumped for joy — well, I would’ve if I could’ve — when I saw a new TV commercial for the Expedia travel company the other day. It shows a woman in winter who’s obviously had enough of the cold, ice, and snow. She is desperate to…
Welcome to “MS News Notes,” a Monday morning column where I comment on multiple sclerosis (MS) news stories that caught my eye last week. Here’s a look at what’s been happening: Another study shows positive results with stem cell therapy Yet another study has concluded that autologous hematopoietic…
It’s been almost two and a half years since my first COVID-19 vaccine — eight months since my most recent booster — and my COVID-19 antibodies seem to still be doing their thing. I know this because, after having nine test tubes of blood drawn, the lab results…
Welcome to “MS News Notes,” a Monday morning column where I comment on multiple sclerosis (MS) news stories that caught my eye last week. Here’s a look at what’s been happening: MS experts offer more than 50 vaccine guidelines I know there are different opinions about vaccines, and I’ve…
“What can Dr. Crayton help you with today?” I was starting my annual multiple sclerosis (MS) checkup with my neurologist, and before I met with her, I got this question from her MS nurse. I was stumped. I’d never been asked that before. I think most people with MS…
Welcome to “MS News Notes,” a Monday morning column where I comment on multiple sclerosis (MS) news stories that caught my eye last week. Here’s a look at what’s been happening: Myelin repair and clemastine The Multiple Sclerosis News Today story “MRI method detects myelin repair with…
I’ve done quite a bit of flying, for business and pleasure, over the 42 years I’ve lived with multiple sclerosis (MS). It’s not easy traveling by air with my scooter, and I can’t imagine trying to fly with a 450-pound power wheelchair. Actually, I don’t have to imagine.
Welcome to “MS News Notes,” a Monday morning column where I comment on multiple sclerosis (MS) news stories that caught my eye last week. Here’s a look at what’s been happening: Foralumab shows early positive results for SPMS I’ll say up front that this is a very small study.
We all know that the difficulty many of us with multiple sclerosis (MS) have walking can be caused by lesions that damage the nerves along the spinal cord. What if an electronic bridge could be built to carry nerve impulses over those damaged areas? That concept is being…
Welcome to “MS News Notes,” a Monday morning column where I comment on multiple sclerosis (MS) news stories that caught my eye last week. Here’s a look at what’s been happening: Is CD40L a better way to control MS inflammation? CD40L is a protein that’s involved with activation of…
Since the early days of the COVID-19 vaccination program, disinformation claiming that the vaccines can induce multiple sclerosis (MS) has swirled around social media. Recently, there’s been a resurgence of this type of post, sparked by a report published on the World Health Organization (WHO) website titled “…
Welcome to “MS News Notes,” a Monday morning column where I comment on multiple sclerosis (MS) news stories that caught my eye last week. Here’s a look at what’s been happening: A closer look at the EBV-MS link Much has been written over the past few years about the…
I’m just back from walking our dog. My wife, Laura, rescued him about a year ago, and when she heard his name was Toby, like Tobias, she thought it was a sign that he was the dog for us. We’ve had dogs before, but I’m not getting any younger or…
Welcome to “MS News Notes,” a Monday morning column where I comment on multiple sclerosis (MS) news stories that caught my eye last week. Here’s a look at what’s been happening: Early stem cell transplants I’ve read the headline “Stem cell therapy may do most good when given…
Memorial Day, the unofficial start of summer vacation in the U.S., is fast approaching. It’s almost time for some summer beach fun — if we can get there. Beaches can be difficult, if not impossible, to access for many people with multiple sclerosis (MS). But times seem to be…
Welcome to “MS News Notes,” a Monday morning column where I comment on multiple sclerosis (MS) news stories that caught my eye last week. Here’s a look at what’s been happening: Surgical treatment of facial pain I’ve never heard of surgery being used as an MS treatment, but…
A recent post on the MS-Selfie blog asks and answers this question: What is the “greatest unmet need” concerning multiple sclerosis (MS)? Professor Gavin Giovannoni, the London-based neurologist who writes that blog, lists five unmet needs, many of which I agree with. But those needs are from the viewpoint…
Welcome to “MS News Notes,” a Monday morning column where I comment on multiple sclerosis (MS) news stories that caught my eye last week. Here’s a look at what’s been happening: Study: Starting Ocrevus early is better than later The MS News Today story “AAN 2023: Early…
Is artificial intelligence (AI) intelligent enough to help make a diagnosis of multiple sclerosis (MS)? Apparently so, and more. In the United Kingdom, a project named AssistMS is studying whether AI can be used to detect and highlight changes on brain MRIs. An algorithm software called…
Explore More Columns
Discussion
Discussion
Discussion